Literature DB >> 2539010

Intrahepatic stones associated with cholangiocarcinoma.

M F Chen1, Y Y Jan, C S Wang, L B Jeng, T L Hwang, S C Chen.   

Abstract

Twenty cases of cholangiocarcinoma associated with hepatolithiasis were treated surgically. The incidence of cholangiocarcinoma associated with hepatolithiasis was 2.4%. Surgical procedures included common bile duct exploration after intraoperative choledochofiberoscopy in 20, with hepatic resection in nine. Overall survival was 8 months, with a range of 3-40 months. The hepatectomy group seemed to have a better prognosis. Accurate preoperative diagnosis of intrahepatic bile duct carcinoma associated with intrahepatic stones is difficult. All 20 patients in this series had surgery for recurrent cholangitis due to intrahepatic stones. From a retrospective review, it became apparent that early diagnosis can be obtained from the following: 1) detection of a hyperechoic mass in the liver parenchyma during abdominal ultrasonography, 2) a scintigraphic defect near the hilum, 3) filling defects or obliteration of intrahepatic ducts in ERCP or PTC, 4) gross appearance of the liver during surgery revealed a nodular tumor mass or an atrophic, fibrotic liver, and 5) intraoperative choledochoscopic findings which showed an intraluminal tumor or infiltrative lesion.

Entities:  

Mesh:

Year:  1989        PMID: 2539010

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  17 in total

1.  A radiomic-based model of different contrast-enhanced CT phase for differentiate intrahepatic cholangiocarcinoma from inflammatory mass with hepatolithiasis.

Authors:  Beihui Xue; Sunjie Wu; Mingyue Zhang; Junjie Hong; Bole Liu; Nina Xu; Qiqiang Zeng; Kun Tang; Xiangwu Zheng
Journal:  Abdom Radiol (NY)       Date:  2021-03-17

2.  Cholangiocarcinoma in the distal bile duct: a probable etiologic association with choledocholithiasis.

Authors:  Masako Nishimura; Shigeyuki Naka; Kazuyoshi Hanazawa; Toru Tani; Masanobu Fukami; Shinta Okada; Yoshihide Fujiyama
Journal:  Dig Dis Sci       Date:  2005-11       Impact factor: 3.199

3.  Outcomes of hepatectomy for hepatolithiasis.

Authors:  Tung-Yen Lee; Yao-Li Chen; Hung-Chi Chang; Chien-Pin Chan; Shou-Jen Kuo
Journal:  World J Surg       Date:  2007-03       Impact factor: 3.352

4.  Hepatolithiasis and cholangiocarcinoma in cystic fibrosis: a case series and review of the literature.

Authors:  David G Perdue; Oliver W Cass; Carlos Milla; Jordan Dunitz; Jose Jessurun; Harvey L Sharp; Sarah J Schwarzenberg
Journal:  Dig Dis Sci       Date:  2007-04-19       Impact factor: 3.199

5.  Impact of concomitant hepatolithiasis on patients with peripheral cholangiocarcinoma.

Authors:  M F Chen; Y Y Jan; T L Hwang; L B Jeng; T S Yeh
Journal:  Dig Dis Sci       Date:  2000-02       Impact factor: 3.199

6.  Clinical studies of mucin-producing cholangiocellular carcinoma: a study of 22 histopathology-proven cases.

Authors:  M F Chen; Y Y Jan; T C Chen
Journal:  Ann Surg       Date:  1998-01       Impact factor: 12.969

7.  Hepatocellular carcinoma complicated with coexisting hepatolithiasis: pitfalls in diagnosis and management.

Authors:  T S Yeh; T C Chen; L L Hsieh; Y Y Jan; L B Jeng; T L Hwang; M F Chen
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

8.  Unusual cases of acute cholecystitis and cholangitis: Tokyo Guidelines.

Authors:  Hideki Yasuda; Tadahiro Takada; Yoshifumi Kawarada; Yuji Nimura; Koichi Hirata; Yasutoshi Kimura; Keita Wada; Fumihiko Miura; Masahiko Hirota; Toshihiko Mayumi; Masahiro Yoshida; Masato Nagino; Yuichi Yamashita; Serafin C Hilvano; Sun-Whe Kim
Journal:  J Hepatobiliary Pancreat Surg       Date:  2007-01-30

Review 9.  Hepatolithiasis and intrahepatic cholangiocarcinoma: A review.

Authors:  Hyo Jung Kim; Jae Seon Kim; Moon Kyung Joo; Beom Jae Lee; Ji Hoon Kim; Jong Eun Yeon; Jong-Jae Park; Kwan Soo Byun; Young-Tae Bak
Journal:  World J Gastroenterol       Date:  2015-12-28       Impact factor: 5.742

10.  [Hepaticolithiasis. Rare benign disease of the intrahepatic bile ducts].

Authors:  C Knorr; A Dimmler; W Hohenberger
Journal:  Chirurg       Date:  2008-05       Impact factor: 0.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.